Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
IJRM-Iranian Journal of Reproductive Medicine. 2012; 10 (4): 363-372
Dans Anglais | IMEMR | ID: emr-132389

Résumé

Osteoporosis is a chronic disease characterized by a decrease in bone mineral density [BMD] and corruption of the microarchitectural structure of bone tissue. It was investigated whether methylprednisolone had a favorable effect on osteoporotic bone tissue in Oophorectomy induced osteoporotic rats whose endogenous adrenaline levels are suppressed with metyrosine. Bone Mineral Density, number of osteoblast-osteoclast, bone osteocalcin levels and alkaline phosphatase [ALP] measurements were performed. Obtained results were compared with that of alendronate. Oophorectomy induced osteoporosis was exacerbated by methylprednisolone. Alentronate prevented ovariectomised induced osteoporosis, but it couldn't prevent methylprednisolone +ovariectomised induced osteoporosis in rats. Combined treatment with methylprednisolon and metyrosine was the best treatment for preventing osteoporosis but metyrosine alone couldn't prevent osteoporosis in ovariectomised rats


Sujets)
Femelle , Animaux de laboratoire , Méthyltyrosines , Rats , Ostéoclastes/effets des médicaments et des substances chimiques , Prednisolone , Prednisolone/effets indésirables , Association médicamenteuse , Ovariectomie/effets indésirables , Ostéoblastes/effets des médicaments et des substances chimiques , Densité osseuse/effets des médicaments et des substances chimiques , Méthylprednisolone/effets indésirables , Méthylprednisolone , Ostéocalcine/effets des médicaments et des substances chimiques , Phosphatase alcaline , Alendronate , Résultat thérapeutique
SÉLECTION CITATIONS
Détails de la recherche